SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-07-002094
Filing Date
2007-07-11
Accepted
2007-07-11 10:12:16
Documents
3
Period of Report
2007-07-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_8k-071007.htm 8-K 28909
2 PRESS RELEASE ISSUED JULY 11, 2007 peregrine_8k-ex9901.htm EX-99.1 180966
3 PEREGRINE LOGO peregrine.jpg GRAPHIC 6031
  Complete submission text file 0001019687-07-002094.txt   220050
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 07973432
SIC: 2835 In Vitro & In Vivo Diagnostic Substances